Daily BriefsSouth Korea

Daily Brief South Korea: SK Biopharmaceuticals , Kangwon Land, Korea Stock Exchange KOSPI 200 and more

In today’s briefing:

  • Key Flow Trading Opportunities After KRX Suddenly Added POSCO Holdings to the BBIG Battery Mix
  • Kangwon Land: Regulatory Improvements to Result in Higher Earnings and Valuation Multiples Expansion
  • EQD | KOSPI 200 OVERSOLD, It Could Bounce This Week


Key Flow Trading Opportunities After KRX Suddenly Added POSCO Holdings to the BBIG Battery Mix

By Sanghyun Park

  • Got surprised by KRX adding POSCO Holdings to the Battery Index. Normally predictable rebalancing went off-script with this unexpected move.
  • POSCO Holdings, not Posco Future M, replaced Ecopro BM. Plus, Alteogen Inc is replacing SK Biopharmaceuticals in the BBIG, driving notable flow.
  • Consider a day trading long POSCO Holdings and short Ecopro BM. Also, a long-short futures basket could be worth exploring for names with big passive flows.

Kangwon Land: Regulatory Improvements to Result in Higher Earnings and Valuation Multiples Expansion

By Douglas Kim

  • Kangwon Land has received approval to expand its total casino area from 14,512 square metres previously to 20,260 square metres (up 40%). 
  • The betting limits in the foreign players only zone will increase significantly from 300,000 won (about US$225) to 300 million won (about US$225,000). This represents a 1000x increase.
  • We would argue that there is a high probability of Kangwon Land benefiting not just from higher sales and profits but also from higher valuation multiples. 

EQD | KOSPI 200 OVERSOLD, It Could Bounce This Week

By Nico Rosti

  • The KOSPI 200 has corrected for 3 weeks in a row, reaching a low at 340.08 last week. It is WEEKLY OVERSOLD, according to our models.
  • In a previous insight we theorized the index could go higher (but only for 1 week), however the rally never materialized. From there it went downhill, now it can bounce.
  • The support area between the last Close and 320 offers strong support, according to our WEEKLY pattern models. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars